secwatch.observer — SEC 8-K summary
======================================

Issuer:     AMARIN CORP PLCUK (AMRN)
CIK:        0000897448
Form:       8-K
Filed at:   2023-04-17T23:59:59+00:00
Accession:  0000950170-23-012983
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Amarin appoints Aaron Berg as Interim CEO and adds Oliver O'Connor to Board, effective April 17, 2023
--------------------------------------------------------------------------------

- Aaron Berg, EVP President-U.S., named Interim CEO and President; board searching for permanent CEO.
- Berg's annual base salary set at $700,000; target bonus remains 50% of base salary.
- Oliver O'Connor appointed to Board and Nominating & Corporate Governance Committee.
- O'Connor brings 30+ years in government, policy, and pharma; currently CEO of Irish Pharmaceutical Healthcare Association.
- Board expands to 8 directors, all independent, including one Irish-domiciled member.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/897448/000095017023012983/0000950170-23-012983-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/897448/000095017023012983/amrn-20230417.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-012983

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer